TRAVUS THERAPEUTICS, INC.
Profile
Company Names
TRAVUS THERAPEUTICS, INC.
Addresses
101 N. CHESTNUT ST., SUITE 104, WINSTON-SALEM, NC 27101
Phone Numbers
(760) 994-8020
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2014
State Incorporated:
DELAWARE
Total Amount Raised:
$750,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2016-06-06
$750,000.00
$2,250,000.00
$1,500,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEREL
DAVIS
DIRECTOR
CHANRX CORP.
| LAGUNA PHARMACEUTICALS, INC.
| INCEPTION IBD, INC.
| TRAVUS THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| TURNSTONE BIOLOGICS CORP.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| CHINOOK THERAPEUTICS U.S., INC.
| VENTUS THERAPEUTICS U.S., INC.
| TENTARIX BIOTHERAPEUTICS, LP
| RAYZEBIO, INC.
| GRAPHITE BIO, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| FIREFLY BIO, INC.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
JOHN
FINN
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
